We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
DNA analyzer manufacturer Bionano Genomics filed for a $30 million IPO, with plans to expand its commercial operations and potentially establish a direct commercialization foothold in China. It plans to use the Nasdaq symbol BNGO.